NZ242920A - Mineral and vitamin supplement for building bone comprising a calcium carboxylate, sources of copper, zinc and manganese and either vitamin d or a diphosphonate - Google Patents

Mineral and vitamin supplement for building bone comprising a calcium carboxylate, sources of copper, zinc and manganese and either vitamin d or a diphosphonate

Info

Publication number
NZ242920A
NZ242920A NZ242920A NZ24292092A NZ242920A NZ 242920 A NZ242920 A NZ 242920A NZ 242920 A NZ242920 A NZ 242920A NZ 24292092 A NZ24292092 A NZ 24292092A NZ 242920 A NZ242920 A NZ 242920A
Authority
NZ
New Zealand
Prior art keywords
calcium
vitamin
diphosphonic acid
manganese
zinc
Prior art date
Application number
NZ242920A
Other languages
English (en)
Inventor
Mark Benson Andon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NZ242920A publication Critical patent/NZ242920A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ242920A 1991-05-28 1992-05-27 Mineral and vitamin supplement for building bone comprising a calcium carboxylate, sources of copper, zinc and manganese and either vitamin d or a diphosphonate NZ242920A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70583291A 1991-05-28 1991-05-28

Publications (1)

Publication Number Publication Date
NZ242920A true NZ242920A (en) 1995-06-27

Family

ID=24835140

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ242920A NZ242920A (en) 1991-05-28 1992-05-27 Mineral and vitamin supplement for building bone comprising a calcium carboxylate, sources of copper, zinc and manganese and either vitamin d or a diphosphonate

Country Status (13)

Country Link
EP (1) EP0586521A1 (cs)
JP (1) JPH07502012A (cs)
KR (1) KR100244603B1 (cs)
AU (1) AU666654B2 (cs)
BR (1) BR9206072A (cs)
CA (1) CA2109958C (cs)
CZ (1) CZ281823B6 (cs)
HU (1) HUT66379A (cs)
IE (1) IE921701A1 (cs)
NO (1) NO934282L (cs)
NZ (1) NZ242920A (cs)
SK (1) SK132693A3 (cs)
WO (1) WO1992021355A1 (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
FR2704393B1 (fr) * 1993-04-30 1995-06-02 Boiron Complément nutritionnel absorbable pour optimiser la croissance et maintenir la solidité des os.
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
FR2723682B1 (fr) * 1994-08-19 1996-09-27 Boiron Complement nutritionnel absorbable pour l'equilibre quotidien de l'enfant et l'adolescent.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US5698222A (en) * 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
WO1998013062A1 (en) * 1996-09-26 1998-04-02 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
NZ336924A (en) * 1997-02-13 2001-06-29 Bone Care Int Inc Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
GB9703109D0 (en) * 1997-02-14 1997-04-02 Smith & Nephew Compositions
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CA2524610C (en) * 2003-05-07 2014-03-25 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
WO2005072539A1 (de) * 2004-01-28 2005-08-11 Dr. Paul Lohmann Gmbh Kg Verfahren zur herstellung einer calcium-laktat-malat verbindung und calcium-laktat-malat verbindung
EP1796683A1 (en) * 2004-07-15 2007-06-20 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
KR20080098616A (ko) * 2006-02-21 2008-11-11 뉴트리조이, 인크. 향상된 맛을 지닌 단백질 함유 식품 또는 음료를 제조하기 위한 조성 및 제조 방법 및 칼슘과 미량 광물질로 영양 보충된 과일 주스
JP5619334B2 (ja) * 2006-06-14 2014-11-05 允聖 崔 骨強化剤
US8889195B2 (en) 2006-08-17 2014-11-18 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
BRPI0715510A2 (pt) * 2006-08-17 2013-06-18 Procter & Gamble composiÇÕes compreendendo citrato-malato de cÁlcio e mÉtodos para produÇço das mesmas
PT2460515T (pt) * 2007-08-09 2017-04-27 Novartis Ag Composições orais de calcitonina e suas aplicações
WO2011028737A2 (en) 2009-09-01 2011-03-10 Duke University Bisphosphonate compositions and methods for treating heart failure
EP2780021A4 (en) 2011-11-16 2015-08-05 Univ Duke BISPHOSPHONATE COMPOSITIONS AND METHODS FOR TREATING AND / OR REDUCING HEART FAILURE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992556A (en) * 1973-05-07 1976-11-16 Vitamins, Inc. Supplemented food product
GB8622025D0 (en) * 1986-09-12 1986-10-22 Beecham Group Plc Composition
FR2618305B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Melange nutritif destine a la personne agee
JP2516794B2 (ja) * 1988-02-26 1996-07-24 雪印乳業株式会社 ビタミンｄ代謝産物を配合した育児用調製乳
EP0343703A3 (en) * 1988-05-26 1990-06-06 The Procter & Gamble Company Mineral supplements with sugar alcohols
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements

Also Published As

Publication number Publication date
AU666654B2 (en) 1996-02-22
HUT66379A (en) 1994-11-28
SK132693A3 (en) 1994-06-08
CZ281823B6 (cs) 1997-02-12
BR9206072A (pt) 1994-11-15
NO934282D0 (no) 1993-11-26
IE921701A1 (en) 1992-12-02
WO1992021355A1 (en) 1992-12-10
JPH07502012A (ja) 1995-03-02
CZ255393A3 (en) 1994-07-13
NO934282L (no) 1994-01-28
CA2109958C (en) 1997-06-10
HU9303364D0 (en) 1994-03-28
KR100244603B1 (ko) 2000-03-02
AU1996892A (en) 1993-01-08
EP0586521A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
AU666654B2 (en) Calcium, trace mineral, vitamin D and drug therapy combinations
EP0583378B1 (en) Combined calcium and vitamin d supplements
US5151274A (en) Calcium and trace mineral supplements
US5232709A (en) Calcium and trace mineral supplements comprising estrogen
US5128374A (en) Use of calcium citrate malate for the treatment of osteoporosis and related disorders
EP0304986B1 (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
US20040048925A1 (en) Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives